0001209191-15-060803.txt : 20150714
0001209191-15-060803.hdr.sgml : 20150714
20150714165121
ACCESSION NUMBER: 0001209191-15-060803
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150710
FILED AS OF DATE: 20150714
DATE AS OF CHANGE: 20150714
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KALOBIOS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001293310
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770557236
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 442 LITTLEFIELD AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650.243.3100
MAIL ADDRESS:
STREET 1: 442 LITTLEFIELD AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GILBERT DENISE
CENTRAL INDEX KEY: 0001224892
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35798
FILM NUMBER: 15987744
MAIL ADDRESS:
STREET 1: 3290 WEST BAYSHORE ROAD
CITY: PALO ALTO
STATE: CA
ZIP: 94303
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-07-10
0
0001293310
KALOBIOS PHARMACEUTICALS INC
KBIO
0001224892
GILBERT DENISE
C/O KALOBIOS PHARMACEUTICALS, INC.
442 LITTLEFIELD AVENUE
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Stock Option (right to buy)
3.68
2015-07-10
4
A
0
5000
0.00
A
2025-07-09
Common Stock
5000
5000
D
The amount of shares covered by this option was 40,000 with an exercise price of $0.46 upon date of grant but subsequently subject to a 1 for 8 reverse stock split on July 13, 2015.
The option shares will vest and become exercisable ratably over 12 months of continuous service after July 10, 2015, subject to the terms of the Company's 2012 Equity Incentive Plan.
/s/ Brian Savage, attorney-in-fact
2015-07-14